Equity benchmarks extended rally in late trade, with the Nifty reclaiming 9900 level.
The 30-share BSE Sensex was up 244.55 points or 0.77 percentat 31,955.54, and the 50-share NSE Nifty rose 73.95 points or 0.75 percent to 9,901.10.
Lupin and Sun Pharma shares gained 1.8 percent each intraday after receiving approval from the US health regulator for drugs.
Pharma major Lupin has received approval from US Food and Drug Administration for Armodafinil that is used to treat excessive sleeping disorder.
For more information & more nifty futures tips
Call us ✆ – 0731-6642300 or
Visit http://ift.tt/1k8NnLH
Connect with our social media sites
Follow @Epic_Research
The 30-share BSE Sensex was up 244.55 points or 0.77 percentat 31,955.54, and the 50-share NSE Nifty rose 73.95 points or 0.75 percent to 9,901.10.
Lupin and Sun Pharma shares gained 1.8 percent each intraday after receiving approval from the US health regulator for drugs.
Pharma major Lupin has received approval from US Food and Drug Administration for Armodafinil that is used to treat excessive sleeping disorder.
For more information & more nifty futures tips
Call us ✆ – 0731-6642300 or
Visit http://ift.tt/1k8NnLH
Connect with our social media sites
Follow @Epic_Research
0 comments:
Post a Comment